|InMed Pharmaceuticals Inc -- USA Stock|| |
USD 0.328 0.002 0.61%
Co-Founder and Sr. VP of Corporate Strategy and Investor RelationsWe currently do not have informatin regarding Christopher Bogart. This executive tanure with InMed Pharmaceuticals Inc is not currenlty determined.
The company has return on total asset (ROA)
of (65.37) %
which means that it has lost $65.37 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (130.15) %
meaning that it generated substantial loss on money invested by shareholders.
InMed Pharmaceuticals Inc., a preclinical stage biopharmaceutical company, engages in the research and development of novel and cannabinoidbased therapies in Canada. InMed Pharmaceuticals Inc (IMLFF) is traded on OTC Market in USA. It is located in Vancouver, BC VC T and employs 6 people.